Join the Minivelle group to help and get support from people like you.
Minivelle News
Long-Term Study of Postmenopausal Women Does Not Support Many Preventive Therapies
THURSDAY, May 2, 2024 – The longitudinal Women's Health Initiative trials do not support hormone therapy for cardiovascular disease prevention, calcium and vitamin D supplementation for universal...
Major Women's Health Study Supports Hormone Replacement Therapy in Early Menopause
WEDNESDAY, May 1, 2024 – Hormone replacement therapy can safely ease middle-aged women’s symptoms during early menopause, data from a major women’s health study show. Women younger than 60 can use ho...
Menopausal Hormone Therapy Use Beyond 65 Years Beneficial
TUESDAY, April 16, 2024 – Use of menopausal hormone therapy beyond age 65 years is associated with risk reductions in mortality as well as specific cancers and cardiovascular diseases, according to...
Treating Vaginal Dryness Around and After Menopause
Wednesday, Feb. 21, 2024 – Postmenopausal or peri-menopausal women are often hampered by vaginal dryness, which can put the brakes on a healthy sex life. It doesn't have to stay that way, experts...
Estrogen Could Be Key to Women's Brain Health
THURSDAY, Sept. 28, 2023 – Being exposed to more estrogen throughout life – or a longer reproductive life span – may be good for the brain, according to new research that found a lower risk of...
Age, Race, Education Most Prevalent Disparities Tied to Menopausal Hormone Therapy Rx
WEDNESDAY, Sept. 27, 2023 – Age, race, and education are the most prevalent disparities associated with menopausal hormone therapy (MHT) prescribing, according to research presented at the annual...
Estrogen Cream Not Always Warranted After Prolapse Surgeries, Study Finds
TUESDAY, Aug. 22, 2023 – Women having surgery for pelvic organ prolapse are often prescribed vaginal estrogen to boost the odds of a successful procedure. Now a clinical trial shows it doesn't...
Noven Receives FDA Approval of a New Indication with a New Dose for Minivelle
Miami, FL and New York, NY, – September 24, 2014 – Noven Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved a new indication with a new dose of...
FDA Medwatch Alert: Olympia Pharmacy Sterile Compounded Products: Recall - Concerns About Sterility Assurance
[Posted 05/30/2013] ISSUE: Lowlite Investments d/b/a Olympia Pharmacy ("Lowlite") notified the public of a voluntary multi-state recall of all sterile drug products compounded by the pharmacy that ...
Ask a question
To post your own question to this support group, sign in or create an account.